NJ Balanced Advantage Fund
The scheme seeks to generate capital appreciation by dynamically allocating its assets between equity and specified debt securities.
Growthvine rating: 2/5 — ranked #21 of 35 in category.
Fund basics
| Category | Hybrid: Balanced Advantage |
|---|
| NAV | ₹13.24 (as of 2026-10-01) |
|---|
| AUM | ₹3,385 Cr |
|---|
| Expense ratio | 1.65% |
|---|
| Riskometer | Moderately High |
|---|
| Fund manager | Jaimin Ilavia |
|---|
| Exit load | 0 |
|---|
Performance & risk
| Sharpe ratio | 0.28 |
|---|
| Standard deviation | 9.59% |
|---|
| Max drawdown | −15.44% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 103.4% of NIFTY 50 Hybrid Composite Debt 50:50 Index's upside and 106.2% of its downside.
Market cap allocation
| Large cap | 63.8% |
|---|
| Mid cap | 24.8% |
|---|
| Small cap | 11.4% |
|---|
Concentration
| Top 5 holdings | 21.7% |
|---|
| Top 10 holdings | 36.4% |
|---|
| Total holdings | 219 |
|---|
Top holdings
- Net Receivable / Payable — 27.9%
- HDFC Bank Ltd. — 5.2%
- Reliance Industries Ltd — 4.8%
- ICICI Bank Ltd. — 4.3%
- Bosch Ltd — 3.8%
- Torrent Pharmaceuticals Ltd. — 3.7%
- Marico Limited — 3.2%
- Dr. Lal Pathlabs Limited — 3.0%
- Eicher Motors Ltd. — 3.0%
- Sun Pharmaceutical Industries Ltd. — 2.8%
Top sectors
Not disclosed.
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −3.1% | Q2 | #17 of 35 |
| 2025 | 1.5% | Q4 (Bottom) | #31 of 34 |
| 2024 | 10.0% | Q4 (Bottom) | #25 of 30 |
| 2023 | 23.0% | Q1 (Top) | #3 of 26 |
| 2022 | −0.2% | Q4 (Bottom) | #17 of 21 |